A Study to Evaluate the Safety, Tolerability, and | Clinical Research Studies Listing

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

Recruiting

35 years - 80 years

All

Phase 1

10 participants needed

1 Location

Brief description of study

The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses of BIIB094 administered via intrathecal (IT) injection to participants with Parkinson's Disease (PD).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Parkinson's Disease
Age: 35 years - 80 years
Gender: All

Males and Females, Age 35-80, Diagnosed with Parkinson's Disease in the last 7 year

Updated on 04 Aug 2024. Study ID: 849949

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

Brief description of study

Eligibility of study

Find a site

Interested in the study